Skip to content

Replimune Group REPL Income Taxes Paid, Net

Income Taxes Paid, Net at other companies

Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0
Incyte logo
IncyteINCY
Moderna logo
ModernaMRNA

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+28.6%
Enterprise value$885.15M+28.3%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's income taxes paid, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's income taxes paid, net?
Replimune Group (REPL) reported income taxes paid, net of $105K in Q4 2024.
How has Replimune Group's income taxes paid, net changed year-over-year?
Replimune Group's income taxes paid, net increased by 40.0% year-over-year, from $75K to $105K.
What does income taxes paid, net mean?
This represents the actual cash outflow for income taxes during the period, net of any refunds received. Unlike the income tax expense reported on the income statement, this figure reflects the timing of actual tax payments to government authorities. It is a key indicator of the company's effective cash tax rate and its ability to manage tax liabilities.